MAFB and COVID-19: Given the overexpression of MAFB-dependent genes in severe COVID-19 pathogenic macrophages, we next assessed the effect of the pharmacological upregulation of MAFB (using the GSK3β inhibitor CHIR99021) on the gene sets that define pathogenic macrophages in severe COVID-19.